AEON Biopharma AEON
NYSE AEON
$0.24 +0.01 (+3.71%)
As of: Oct 21, 2026 · 12:42 PM EDT

AEON Biopharma (AEON) EV to EBITDA (2025)

Updated

AEON Biopharma's (AEON) EV to EBITDA stood at 0.00 in Q2 2025.

Analysis

AEON Biopharma (AEON) EV to EBITDA (2025) Analysis & Trends

On a TTM basis, AEON Biopharma's EV to EBITDA came in at -0.07 as of Jun 30, 2025; for FY2024, it came in at 0.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.02 Bn 1,101.60 Bn 19.71 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.78 Bn 321.16 Bn 12.21 Bn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.44 Bn 190.84 Bn 7.24 Bn
8 Gilead Sciences 190.69 Bn 164.89 Bn 6.22 Bn
9 Pfizer 169.52 Bn 116.16 Bn 10.94 Bn
10 AEON Biopharma 12.13 Mn -8.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Mar 31, 2025 -0.11
API Access

AEON Biopharma EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AEON&period=max&api_key=YOUR_API_KEY